Julia Belluz: Today, the FDA is now considered the fastest regulatory agency in the world. But there’s some concern that these expedited pathways are being used by drug companies to speed through medicines that aren’t actually helping patients with unmet medical needs — and that often aren’t any improvement over what’s already on the market

Quick Read

A prototype 3D-printed robotic hand that can be made faster and more cheaply than current alternatives is this year’s UK winner of the James Dyson Award

Quick Read

The global pharmaceutical industry is being called on to pay for a $2bn (£1.3bn) innovation fund to revitalise research into antibiotics

Quick Read

A small benefits consulting firm called ELAP Services is causing commotion by suggesting an alternative: Refuse to pay. When hospitals send invoices with charges that seem to bear no relationship to their costs, the Pennsylvania firm tells its clients (generally medium-sized employers) to just say no

Quick Read

Hepatitis C drug Sovaldi strains programs for the poor; Texas didn’t pay for it last year

Quick Read

There is an increasing body of evidence to suggest that significant quantities of medicines and medical products, especially in low and middle-income countries, are of poor quality. Malaria researcher and drug quality expert Professor Paul Newton, of the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit in Laos, explains the latest research findings

Quick Read

Matthew DeCamp, MD, PhD discusses the factors that influence physician referrals and his roadmap for how health care organizations can influence referrals in ways that respect choice and protect patient well-being

Read More